首頁 >> 供求商機
R-(+)-DIHYDROZEATIN (R-DZ) [(+)-6-(R)-(4-hydroxy-3-methylbutylamino)purine]
| MW 221.26; crystalline; purity > 98% (HPLC) | ||
| S:26, 36; CAS: 37789-32-5; C10H15N5O | ||
| 028 0601 | 1 | mg |
| 028 0602 | 2 | mg |
| 028 0603 | 2 | mg |
S-(-)-DIHYDROZEATIN (S-DZ) [(-)-6-(S)-(4-hydroxy-3-methylbutylamino)purine]
| MW 221.26; crystalline; purity > 98% (HPLC) | ||
| S:26, 36; CAS: 14742-97-3; C10H15N5O | ||
| 029 0601 | 1 | mg |
| 029 0602 | 2 | mg |
| 029 0603 | 5 | mg |
R-(-)-DIHYDROZEATIN RIBOSIDE (R-DZR) [(-)-6-(R)-4-hydroxy-3-methylbutylamino-9-β-D-ribofuranosylpurine]
| MW 353.38; crystalline; purity > 97% (HPLC) | ||
| S:26, 36; CAS: 64070-21-9; C15H23N5O5 | ||
| 028 0611 | 1 | mg |
| 028 0612 | 2 | mg |
| 028 0613 | 5 | mg |
S-(-)-DIHYDROZEATIN RIBOSIDE (S-DZR) [(-)-6-(S)-4-hydroxy-3-methylbutylamino-9-β-D-ribofuranosylpurine]
| MW 353.38; crystalline; purity > 97% (HPLC) | ||
| S:26, 36; CAS: 64070-22-0; C15H23N5O5 | ||
| 029 0611 | 1 | mg |
| 029 0612 | 2 | mg |
| 029 0613 | 5 | mg |
R-(-)-DIHYDROZEATIN RIBOSIDE-5'-MONOPHOSPHATE SODIUM SALT (R-DZMP) [(-)-6-(R)-(4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]
| MW 497.35; crystalline; purity > 95% (HPLC) | ||
| S:26, 36; CAS: NONE; C15H22N5Na2O8P.H2O | ||
| 028 5011 | 1 | mg |
| 028 5012 | 2 | mg |
| 028 5013 | 5 | mg |
17